Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 4/20 | 0.86 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.58 |
| ▸ | APAF1 | O14727 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL8818249 | 1.00 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL7713436 | 1.00 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL10478288 | 1.00 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL2794537 | 1.00 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL2705733 | 1.00 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL3417348 | 1.00 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL136460 | 1.00 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL4494449 | 0.97 | SLC22A1 (0.80) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL14720249 | 0.97 | SLC22A1 (0.80) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL2794532 | 0.97 | SLC22A1 (0.80) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3737 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036521-A | Process for synthesizing high-purity tetrabutylammonium fluoride trihydrate | 上海沃凯生物技术有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4735459-A1 | METHODS AND INTERMEDIATES FOR PREPARING ANTIVIRAL PRODRUGS | GILEAD SCIENCES, INC. (US) | 2026-05-06 | — | — | EP | claimed |
| US-20260092239-A1 | CLEANING COMPOSITION | DONGWOO FINE CHEM CO LTD (KR) | 2026-04-02 | — | — | US | claimed |
| WO-2025203035-A1 | AN IMPROVED PROCESS FOR PREPARATION OF 25-OH PROVITAMIN D3(CALCIFEDIOL) | FERMENTA BIOTECH LIMITED (IN) | 2025-10-02 | — | — | WO | claimed |
| US-20250179111-A1 | METHOD FOR SYNTHESIZING HIGH-PURITY PLANT-DERIVED CHOLESTEROL | EAST CHINA NORMAL UNIVERSITY (CN) | 2025-06-05 | — | — | US | claimed |
| US-20250145658-A1 | SYNTHESIS METHOD FOR HIGH-PURITY CHOLESTEROL | EAST CHINA NORMAL UNIVERSITY (CN) | 2025-05-08 | — | — | US | claimed |
| WO-2025006582-A1 | METHODS AND INTERMEDIATES FOR PREPARING ANTIVIRAL PRODRUGS | GILEAD SCIENCES, INC. (US) | 2025-01-02 | — | — | WO | claimed |
| EP-4471044-A1 | METHOD FOR SYNTHESIZING HIGH-PURITY PLANT-DERIVED CHOLESTEROL | East China Normal University (CN) | 2024-12-04 | — | — | EP | claimed |
| EP-4471045-A1 | SYNTHESIS METHOD FOR HIGH-PURITY CHOLESTEROL | East China Normal University (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-118994115-A | Preparation and application of novel compound for treating methamphetamine addiction and cognitive dysfunction | 宁波大学 | 2024-11-22 | — | — | CN | claimed |
| US-6207822-B1 | REACTING P-FLUOROBENZOYLBUTYRIC ACID WITH PIVALOYL CHLORIDE;ACYLATION; REDUCTION; CYCLIZATION; HYDROSILATION; DEBLOCKING | SCHERING CORPORATION | 2001-03-27 | — | — | US | claimed |
| WO-2000034240-A1 | PROCESS FOR THE SYNTHESIS OF AZETIDINONES | SCHERING CORPORATION (US) | 2000-06-15 | — | — | WO | claimed |
| US-6028216-A | Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives | GUILFORD PHARMACEUTICALS INC. (US) | 2000-02-22 | — | — | US | claimed |
| WO-1999033848-A1 | PROCESS FOR PREPARING ENANTIOMER-ENRICHED HYDROXYPHOSPHINYL DERIVATIVES | GUILFORD PHARMACEUTICALS INC. (US) | 1999-07-08 | — | — | WO | claimed |
| EP-0716648-B1 | NEW 9-CHLORO-PROSTAGLANDIN DERIVATIVES | SCHERING AG (DE) | 1998-10-28 | — | — | EP | claimed |
| US-5756818-A | 9-chloro-prostaglandin derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-05-26 | — | — | US | claimed |
| EP-0716648-A1 | NEW 9-CHLORO-PROSTAGLANDIN DERIVATIVES | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-06-19 | — | — | EP | claimed |
| WO-1995006634-A1 | NEW 9-CHLORO-PROSTAGLANDIN DERIVATIVES | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-03-09 | — | — | WO | claimed |
| US-4857652-A | Chemiluminescent 1,2-dioxetane compounds | BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) | 1989-08-15 | — | — | US | claimed |
| EP-0199490-A1 | Penem derivatives | FARMITALIA CARLO ERBA S.r.l. (IT) | 1986-10-29 | — | — | EP | claimed |